SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-164015
Filing Date
2024-06-20
Accepted
2024-06-20 08:13:58
Documents
19
Period of Report
2024-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d857887d8k.htm   iXBRL 8-K 32479
2 EX-1.1 d857887dex11.htm EX-1.1 196281
3 EX-5.1 d857887dex51.htm EX-5.1 13791
4 EX-99.1 d857887dex991.htm EX-99.1 29461
9 GRAPHIC g857887g0619071649183.jpg GRAPHIC 8821
10 GRAPHIC g857887g0619071808145.jpg GRAPHIC 2534
  Complete submission text file 0001193125-24-164015.txt   515872

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tpst-20240620.xsd EX-101.SCH 3349
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tpst-20240620_def.xml EX-101.DEF 13624
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tpst-20240620_lab.xml EX-101.LAB 22653
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tpst-20240620_pre.xml EX-101.PRE 14402
22 EXTRACTED XBRL INSTANCE DOCUMENT d857887d8k_htm.xml XML 5855
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 241054148
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)